Table 2

Overlap phenotype in severe asthma

Author (year)n (%)% maleFEV1, predicted, post bronchodilatorDurationAge of onsetOCS maintenance, %Airway inflammatory
phenotype
Moore (2010)24116 (15.9)375847E|N
Jang (2013)2821 (21.9)38492424N
Ghebre et al, (2015)2147 (27.4)5560940N
Newby (2014)2354 (15.4)43532557
Bourdin (2014) (A)2621 (18.8)57503462
Bourdin (2014) (B)2630 (26.8)57523257
Moore (2014)2947 (11.1)5761282226N
Ortega (2014)27102 (16.6)20.5661933E
  • E, eosinophilic; N, neutrophilic; OCS, oral corticosteroid.